These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3457968)

  • 1. Rauwolfia use and breast cancer: a case-control study.
    Stanford JL; Martin EJ; Brinton LA; Hoover RN
    J Natl Cancer Inst; 1986 May; 76(5):817-22. PubMed ID: 3457968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program.
    Williams RR; Feinleib M; Connor RJ; Stegens NL
    J Natl Cancer Inst; 1978 Aug; 61(2):327-35. PubMed ID: 277719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term use of antihypertensive drugs and risk of cancer.
    Assimes TL; Elstein E; Langleben A; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rauwolfia derivatives and breast cancer.
    Lilienfeld AM; Chang L; Thomas DB; Levin ML
    Johns Hopkins Med J; 1976 Aug; 139(2):41-50. PubMed ID: 957533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension, diuretics and breast cancer risk.
    Largent JA; McEligot AJ; Ziogas A; Reid C; Hess J; Leighton N; Peel D; Anton-Culver H
    J Hum Hypertens; 2006 Oct; 20(10):727-32. PubMed ID: 16885996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
    Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
    Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
    Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R
    Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazide diuretics and the risk of gallbladder disease requiring surgery in women.
    Leitzmann MF; Tsai CJ; Stampfer MJ; Willett WC; Giovannucci E
    Arch Intern Med; 2005 Mar; 165(5):567-73. PubMed ID: 15767534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced fracture risk in users of thiazide diuretics.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2005 Mar; 76(3):167-75. PubMed ID: 15719207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for cancer of the breast due to previous medication.
    de Levin RW; Puig OR; Levin E
    Arch Geschwulstforsch; 1984; 54(2):153-8. PubMed ID: 6732438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
    Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
    Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement therapy and benign breast disease.
    Trapido EJ; Brinton LA; Schairer C; Hoover R
    J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Yoo KY; Kang D
    BMC Cancer; 2005 Oct; 5():143. PubMed ID: 16259637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Rauwolfia derivatives and breast cancer.
    Med J Aust; 1974 Nov; 2(20):722. PubMed ID: 4444628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.